Literature DB >> 16260273

eIF-4E expression is associated with histopathologic grades in cervical neoplasia.

Jeong-Won Lee1, Jung-Joo Choi, Kyoung Mee Lee, Chel Hun Choi, Tae-Joong Kim, Je-Ho Lee, Byoung-Gie Kim, Geunghwan Ahn, Sang Yong Song, Duk-Soo Bae.   

Abstract

Translation initiation factor eIF-4E (eukaryotic initiation factor 4E) is a 25 kd messenger RNA cap-binding phosphoprotein and is involved in the initiation of protein synthesis. The expression is known to be elevated in several carcinomas as compared with normal tissues and benign lesions. In the present study, we undertook to determine whether eIF-4E expression is associated with progression in cervical neoplasia. eIF-4E expression was evaluated by immunohistochemistry in 88 formalin-fixed, paraffin-embedded cervical tissues; 10 normal cervical specimens; 19 low-grade cervical intraepithelial neoplasias (CINs); 19 high-grade CINs; and 40 invasive squamous cell carcinomas (ISCCs). In addition, eIF-4E expression was evaluated at the RNA level in fresh frozen cervical carcinoma tissues by real-time quantitative reverse transcriptase polymerase chain reaction. Immunohistochemical staining showed that eIF-4E expression was undetectable in most normal cervical squamous epithelial tissues (90%), but variable staining was observed in the basal layer of all normal endocervical glands. eIF-4E expression, which was mainly observed as cytoplasmic staining, gradually increased in accordance with histopathologic grade in the order low-grade CIN < high-grade CIN < ISCC (P < .001) and, in particular, was strongly detected in all ISCC cases. Furthermore, real-time quantitative reverse transcriptase polymerase chain reaction revealed that eIF-4E expression in tumor was significantly enhanced versus normal cervical tissues (P = .037). These results suggest that eIF-4E may play a significant role in tumor progression of cervical neoplasia and may represent useful markers for malignant transformation of cervical squamous cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16260273     DOI: 10.1016/j.humpath.2005.08.010

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  12 in total

Review 1.  Ribavirin as an anti-cancer therapy: acute myeloid leukemia and beyond?

Authors:  Katherine L B Borden; Biljana Culjkovic-Kraljacic
Journal:  Leuk Lymphoma       Date:  2010-10

Review 2.  The oncogene eIF4E: using biochemical insights to target cancer.

Authors:  Martin Carroll; Katherine L B Borden
Journal:  J Interferon Cytokine Res       Date:  2013-03-08       Impact factor: 2.607

3.  Treatment of breast and lung cancer cells with a N-7 benzyl guanosine monophosphate tryptamine phosphoramidate pronucleotide (4Ei-1) results in chemosensitization to gemcitabine and induced eIF4E proteasomal degradation.

Authors:  Shui Li; Yan Jia; Blake Jacobson; Joel McCauley; Robert Kratzke; Peter B Bitterman; Carston R Wagner
Journal:  Mol Pharm       Date:  2013-02-04       Impact factor: 4.939

4.  HPV18 E7 induces the over-transcription of eIF4E gene in cervical cancer.

Authors:  Tianyun Pang; Sen Wang; Min Gao; Haixian Kang; Yi Zhao; Yunhong Yao; Xinrong Hu
Journal:  Iran J Basic Med Sci       Date:  2015-07       Impact factor: 2.699

5.  Eukaryotic translation initiation factor 3 subunit D overexpression is associated with the occurrence and development of ovarian cancer.

Authors:  Yaying Lin; Rongrong Zhang; Ping Zhang
Journal:  FEBS Open Bio       Date:  2016-10-31       Impact factor: 2.693

6.  Expression of 4E-BP1 and phospho-4E-BP1 correlates with the prognosis of patients with clear cell renal carcinoma.

Authors:  Feng Li; Qingshui Wang; Xiaoxue Xiong; Chenyi Wang; Xiaohua Liu; Ziqiang Liao; Ke Li; Bifeng Xie; Yao Lin
Journal:  Cancer Manag Res       Date:  2018-06-15       Impact factor: 3.989

7.  Clinical Significance of Eukaryotic Initiation Factor 4E (eIF4E) Level among Cases Suffering Basal Cell Carcinoma of Skin.

Authors:  Baiyu Han; Qinying Zhang; GaiLan Li; Rui Zhang; Hengjin Li
Journal:  Med Sci Monit       Date:  2019-10-23

8.  Combined analysis of eIF4E and 4E-binding protein expression predicts breast cancer survival and estimates eIF4E activity.

Authors:  L J Coleman; M B Peter; T J Teall; R A Brannan; A M Hanby; H Honarpisheh; A M Shaaban; L Smith; V Speirs; E T Verghese; J N McElwaine; T A Hughes
Journal:  Br J Cancer       Date:  2009-04-14       Impact factor: 7.640

9.  Understanding and Targeting the Eukaryotic Translation Initiation Factor eIF4E in Head and Neck Cancer.

Authors:  Biljana Culjkovic; Katherine L Borden
Journal:  J Oncol       Date:  2009-12-13       Impact factor: 4.375

Review 10.  Role of RONS and eIFs in Cancer Progression.

Authors:  Yasmeen Ahmed Salaheldin; Salma Sayed Mohamed Mahmoud; Ebenezeri Erasto Ngowi; Vivian Aku Gbordzor; Tao Li; Dong-Dong Wu; Xin-Ying Ji
Journal:  Oxid Med Cell Longev       Date:  2021-07-05       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.